Liver carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
The data establish the 14-3-3ζ-HO-1-STAT3 axis as an important regulatory mechanism of cancer cell growth and implicate HO-1 and 14-3-3ζ as potential therapeutic targets in hepatocellular carcinoma.
|
30606233 |
2019 |
Liver carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
However, HO-1 expression did not seem to influence the prognosis of HCC patients.
|
31261522 |
2019 |
Liver carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
We identified HO-1 as a favorable prognostic factor for HBV-HCC patients who underwent hepatectomy.
|
30538554 |
2018 |
Liver carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
All of our data confirmed that oxidative stress-mediated mitochondrial apoptosis (especially the Nrf-2/HO-1 pathway) is responsible for 5h2c-induced HCC damage.
|
30055129 |
2018 |
Liver carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Moreover, TGF-β1-induced cell cycle arrest and up-regulation of cyclin-dependent kinase inhibitors in HCC cell lines were significantly attenuated by overexpression of HO-1 or treatment with tricarbonyldichlororuthenium(II) dimer ([Ru(CO)<sub>3</sub>Cl<sub>2</sub>]<sub>2</sub>, suggesting an inhibitory role of the HO-1/CO axis in TGF-β signaling to growth inhibition in HCC cell lines.
|
29524413 |
2018 |
Liver carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Compared to controls, almost a 3 times higher mRNA level of BLVRA was detected in livers of HCC patients (p = 0.002); while those of BLVRB as well as HMOX1 were unchanged (p > 0.05).
|
27740521 |
2017 |
Liver carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Akt and ERK pathways may be involved in the regulation of HO-1/miR-30d/miR-107 in HCC.
|
27571925 |
2016 |
Liver carcinoma
|
0.100 |
Biomarker
|
disease |
LHGDN |
In conclusion, a specific knockdown of HO-1 might represent a novel therapeutic approach in HCC therapy.
|
18566988 |
2008 |
Liver carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Mechanism of action of sulforaphane: inhibition of p38 mitogen-activated protein kinase isoforms contributing to the induction of antioxidant response element-mediated heme oxygenase-1 in human hepatoma HepG2 cells.
|
16951197 |
2006 |
Liver carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
In the present study, we investigated the transcriptional levels of NAD(P)H:quinone oxidoreductase 1 (NQO1) and heme oxygenase 1 (HO1) genes, the reporter activity mediated by antioxidant response element (ARE), and the protein level of transcription factor nuclear factor E2-related factor 2 (Nrf2), after administration of three major garlic OSCs--diallyl sulfide (DAS), diallyl disulfide (DADS), and diallyl trisulfide (DATS)--in human hepatoma HepG2 cells.
|
15477009 |
2004 |
Liver carcinoma
|
0.100 |
AlteredExpression
|
disease |
LHGDN |
We examined changes in heme metabolism by analyzing gene expression of the non-specific delta-aminolevulinate synthase (ALAS-N), and heme oxygenase-1 (HO-1), the rate limiting enzyme in heme synthesis and catabolism, respectively, in the human hepatoma cell line HLE/2E1, in which CYP2E1 was overexpressed by transfection of its expression vector.
|
12469218 |
2003 |
Liver carcinoma
|
0.100 |
AlteredExpression
|
disease |
LHGDN |
Co-operation of the transcription factor hepatocyte nuclear factor-4 with Sp1 or Sp3 leads to transcriptional activation of the human haem oxygenase-1 gene promoter in a hepatoma cell line.
|
12133007 |
2002 |